The weight reduction observed with GLP-1 therapy is not merely a side effect but represents a therapeutic benefit for many patients with type 2 diabetes, who often struggle with overweight or obesity
Indications and mechanism of action As described by Liu, GLP-1 pathophysiology involves multiple mechanisms of action that improve glucose control and promote weight loss, including enhanced insulin secretion, inhibited glucagon release, delayed gastric emptying, increased satiety, and improved insulin sensitivity
Available from: www.ncbi.nlm.nih.gov/books/NBK537088/PubMed%20PMID:%2030725773/ Ureshino RP, Erustes AG, Bassani TB, Wachilewski P, Guarache GC, Nascimento AC, Costa AJ, Smaili SS, da Silva Pereira GJ (2019) The interplay between Ca2 + signaling pathways and neurodegeneration
1A, 2A)
Revenue grew 95% compared to the same quarter in 2023